| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $13.6M | +10.0% |
| SG&A Expense | $11.9M | -2.4% |
| Operating Income | -$25.5M | -13.1% |
| Interest Expense | $13K | -13.3% |
| Pre-tax Income | -$26.0M | -4.4% |
| Income Tax | $0 | -100.0% |
| Net Income | -$20.3M | -5.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.4M | -22.1% |
| Accounts Receivable | $102K | -41.0% |
| Current Assets | $10.7M | -60.7% |
| Total Assets | $11.0M | -66.9% |
| Current Liabilities | $10.6M | +37.8% |
| Total Liabilities | $29.6M | +7.9% |
| Stockholders' Equity | -$24.7M | -129.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.1M | -19.1% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $4.4M | — |
| Financing Cash Flow | $12.0M | -18.7% |
| Free Cash Flow | -$19.1M | -18.9% |